The Dialysis Centers industry has performed well because it is crucial for patients with chronic kidney disease, making demand for services inelastic. The only substitute available for dialysis treatment is a kidney transplant, which typically entails many years of waiting and uncertainty. Even throughout the COVID-19 pandemic, when nonessential healthcare services were temporarily prohibited in many places, demand for dialysis continued to grow. Revenue has increased at a CAGR of 2.4% to an estimated $36.0 billion over the five years to 2023, including 4.2% growth in 2023 alone.Life blood: Rising federal funding for Medicare and Medicaid is projected to drive industry expansion
The Dialysis Centers industry includes medical facilities that provide inpatient and outpatient kidney or renal dialysis services.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Table of Contents
ABOUT THIS INDUSTRY
INDUSTRY PERFORMANCE
PRODUCTS & MARKETS
COMPETITIVE LANDSCAPE
OPERATING CONDITIONS
KEY STATISTICS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Fresenius Medical Care Ag & Co. Kgaa
- DaVita HealthCare Partners Inc.
Methodology
LOADING...